Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancers|December 31, 2020
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem CellsMargaret L Dahn, Paola MarcatoMethods in Molecular Biology (Clifton, N.J.)|September 30, 2021
In Vivo Genome-Wide Pooled RNAi Screens in Cancer Cells to Identify Determinants of Chemotherapy/Drug ResponseMargaret L Dahn, Paola MarcatoFrontiers in Oncology|February 7, 2022
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential TargetingOlivia L Walker, Margaret L Dahn, Melanie R Power Coombs, et al.Clinical and Translational Radiation Oncology|July 3, 2025
Online CBCT-based adaptive radiation with reduced PTV margins for prostate cancer: Does reference plan comparison tell the whole story?Margaret L Dahn, R Lee MacDonald, Amanda Cherpak, et al.Molecular Therapy. Methods & Clinical Development|February 12, 2021
Human-specific GAPDH qRT-PCR is an accurate and sensitive method of xenograft metastasis quantificationMargaret L Dahn, Cheryl A Dean, Diana B Jo, et al.Metabolomics : Official Journal of the Metabolomic Society|January 6, 2022
Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasisMargaret L Dahn, Hayley R Walsh, Cheryl A Dean, et al.Cancers|December 10, 2020
S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample AnalysisAlamelu G Bharadwaj, Margaret L Dahn, Rong-Zong Liu, et al.Cancers|June 2, 2021
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast CancerBrianne M Cruickshank, Marie-Claire D Wasson, Justin M Brown, et al.Molecular Oncology|May 1, 2021
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancerMohammad Sultan, Jacob T Nearing, Justin M Brown, et al.Molecular Cancer Therapeutics|March 12, 2020
Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug ResistanceMargaret L Dahn, Brianne M Cruickshank, Ainsleigh J Jackson, et al.Pageof 2